Stock Analysis on Net

Regeneron Pharmaceuticals Inc. (NASDAQ:REGN)

$24.99

Common-Size Balance Sheet: Assets
Quarterly Data

Paying user area

The data is hidden behind: . Unhide it.

This is a one-time payment. There is no automatic renewal.


We accept:

Visa Mastercard American Express Maestro Discover JCB PayPal Google Pay
Visa Secure Mastercard Identity Check American Express SafeKey

Regeneron Pharmaceuticals Inc., common-size consolidated balance sheet: assets (quarterly data)

Microsoft Excel
Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Cash and cash equivalents
Marketable securities
Accounts receivable, net
Inventories
Prepaid expenses and other current assets
Current assets
Marketable securities
Property, plant, and equipment, net
Intangible assets, net
Deferred tax assets
Other noncurrent assets
Noncurrent assets
Total assets

Based on: 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).


Cash and Cash Equivalents
The proportion of cash and cash equivalents relative to total assets shows moderate fluctuation over the periods. Initially, it declined from 14.01% in March 2020 to a low of 6.32% in June 2023, then exhibits a slight recovery reaching 8.23% by March 2025. Overall, there is a downward trend with intermittent increases.
Marketable Securities
The share of marketable securities within total assets exhibits an increasing trend from early 2020 through 2023, peaking around 24-25% during late 2023 and early 2024, before gradually declining to 14.01% by March 2025. This indicates an overall growing allocation towards liquid market investments for most of the observed period, followed by a reduction towards the end.
Accounts Receivable, Net
Accounts receivable as a percentage of total assets display variability with a peak of 32.57% in June 2021, followed by a general downward trend to 14.81% in March 2025. This suggests a high concentration of receivables around mid-2021 and a moderation in subsequent quarters, possibly reflecting changes in credit policies or collection efficiency.
Inventories
The inventory proportion remains fairly stable, fluctuating mostly within the 7.5%-12% range. A slight peak is observable around March 2021 at 12.18%, but generally, inventory as a percentage of assets holds steady near 8% in recent periods, indicating consistent inventory management.
Prepaid Expenses and Other Current Assets
This component shows minor fluctuations, generally remaining below 2.1% of total assets. There is no clear long-term trend, with values oscillating between approximately 0.9% and 2.1%, suggesting these assets represent a small and stable portion of total assets.
Current Assets
The proportion of current assets to total assets remains above 46%, with peaks near 62% in mid-2021, followed by a gradual decline to 46.8% in March 2025. This indicates that current assets constitute the majority of total assets but have been decreasing in relative importance in recent quarters.
Property, Plant, and Equipment, Net
There is a noticeable downward trend in the proportion of property, plant, and equipment from highs above 21% in June 2020 to lower levels near 12.5% by early 2025. This reflects either asset disposals, revaluation, or a shift in asset composition away from physical assets.
Intangible Assets, Net
Intangible assets data are missing for early periods but appear consistently around 3% of total assets from late 2022 onward, with slight variations. This suggests a modest and stable contribution of intangibles to the asset base in recent periods.
Deferred Tax Assets
Deferred tax assets as a percentage of total assets have increased steadily from around 4.3%-5.4% during 2020 to over 9% in March 2025, indicating greater recognition or realization of deferred tax benefits over time.
Other Noncurrent Assets
The share of other noncurrent assets has shown a progressive increase from approximately 0.6%-1.2% in early periods to 3.7% by March 2025. This growth may imply increased investments or holdings classified under noncurrent assets.
Noncurrent Assets
The overall proportion of noncurrent assets demonstrates a roughly stable-to-increasing trend, moving from around 45% in early 2020 to over 53% by March 2025. This suggests a strategic shift or growth in longer-term asset holdings over this horizon.